Ignite Creation Date:
2025-12-24 @ 1:40 PM
Ignite Modification Date:
2026-01-29 @ 8:06 AM
Study NCT ID:
NCT06045195
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-04-06
First Post:
2023-09-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab in First-Line Treatment of Advanced-Stage Classical Hodgkin Lymphoma
Sponsor:
Organization: